{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:48Z","timestamp":1792788288724,"version":"4.5.0"},"reference-count":52,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>The BCG vaccine\u2014used worldwide to prevent tuberculosis\u2014confers multiple nonspecific beneficial effects, and intravesical BCG vaccine is currently the recommended treatment for non\u2013muscle-invasive bladder cancer (NMIBC). Moreover, BCG vaccine has been hypothesized to reduce the risk of Alzheimer disease and related dementias (ADRD), but previous studies have been limited by sample size, study design, or analyses.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate whether intravesical BCG vaccine exposure is associated with a decreased incidence of ADRD in a cohort of patients with NMIBC while accounting for death as a competing event.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cohort study was performed in patients aged 50 years or older initially diagnosed with NMIBC between May 28, 1987, and May 6, 2021, treated within the Mass General Brigham health care system. The study included a 15-year follow-up of individuals (BCG vaccine treated or controls) whose condition did not clinically progress to muscle-invasive cancer within 8 weeks and did not have an ADRD diagnosis within the first year after the NMIBC diagnosis. Data analysis was conducted from April 18, 2021, to March 28, 2023.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The main outcome was time to ADRD onset identified using diagnosis codes and medications. Cause-specific hazard ratios (HRs) were estimated using Cox proportional hazards regression after adjusting for confounders (age, sex, and Charlson Comorbidity Index) using inverse probability scores weighting.<\/jats:p><\/jats:sec>Results<\/jats:title>In this cohort study including 6467 individuals initially diagnosed with NMIBC between 1987 and 2021, 3388 patients underwent BCG vaccine treatment (mean [SD] age, 69.89 [9.28] years; 2605 [76.9%] men) and 3079 served as controls (mean [SD] age, 70.73 [10.00] years; 2176 [70.7%] men). Treatment with BCG vaccine was associated with a lower rate of ADRD (HR, 0.80; 95% CI, 0.69-0.99), with an even lower rate of ADRD in patients aged 70 years or older at the time of BCG vaccine treatment (HR, 0.74; 95% CI, 0.60-0.91). In competing risks analysis, BCG vaccine was associated with a lower risk of ADRD (5-year risk difference, \u22120.011; 95% CI, \u22120.019 to \u22120.003) and a decreased risk of death in patients without an earlier diagnosis of ADRD (5-year risk difference, \u22120.056; 95% CI, \u22120.075 to \u22120.037).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this study, BCG vaccine was associated with a significantly lower rate and risk of ADRD in a cohort of patients with bladder cancer when accounting for death as a competing event. However, the risk differences varied with time.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.14336","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T15:31:18Z","timestamp":1684510278000},"page":"e2314336","source":"Crossref","is-referenced-by-count":39,"title":["Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non\u2013Muscle-Invasive Bladder Cancer"],"prefix":"10.1001","volume":"6","author":[{"given":"Marc S.","family":"Weinberg","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Department of Neurology, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Affan","family":"Zafar","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Urology, Massachusetts General Hospital, Boston"},{"name":"Division of Urology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Magdamo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Chung","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley H.","family":"Chou","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Urology, Oregon Health and Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhur","family":"Nayan","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Urology, Massachusetts General Hospital, Boston"},{"name":"Division of Urology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Urology, New York University, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuresh","family":"Deodhar","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Frendl","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Urology, Massachusetts General Hospital, Boston"},{"name":"Department of Urology, Mayo Clinic, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Urology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise L.","family":"Faustman","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Immunobiology Laboratories, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bella","family":"Vakulenko-Lagun","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Haifa, Mt Carmel, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeshna","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"issue":"4","key":"zoi230439r1","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/alz.v18.4","article-title":"2022 Alzheimer\u2019s disease facts and figures.","volume":"18","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"2","key":"zoi230439r2","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","journal-title":"Lancet Public Health"},{"issue":"1","key":"zoi230439r3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease.","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi230439r4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2022.0315","article-title":"Cost-effectiveness of aducanumab and donanemab for early Alzheimer disease in the US.","volume":"79","author":"Ross","year":"2022","journal-title":"JAMA Neurol"},{"issue":"1","key":"zoi230439r5","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/S2666-7568(21)00301-9","article-title":"A whole-population approach is required for dementia risk reduction.","volume":"3","author":"Walsh","year":"2022","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"zoi230439r6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/imr.v297.1","article-title":"The role of innate immunity in Alzheimer\u2019s disease.","volume":"297","author":"Ennerfelt","year":"2020","journal-title":"Immunol Rev"},{"issue":"2","key":"zoi230439r7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1021\/acschemneuro.8b00402","article-title":"Targeting neuroinflammation as a therapeutic strategy for Alzheimer\u2019s disease: mechanisms, drug candidates, and new opportunities.","volume":"10","author":"Fu","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"zoi230439r8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872542","article-title":"Adult vaccination as a protective factor for dementia: a meta-analysis and systematic review of population-based observational studies.","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"zoi230439r11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/01.inf.0000129693.81082.a0","article-title":"Low birth weight infants and Calmette-Gu\u00e9rin bacillus vaccination at birth: community study from Guinea-Bissau.","volume":"23","author":"Roth","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"7274","key":"zoi230439r12","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/bmj.321.7274.1435","article-title":"Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa.","volume":"321","author":"Kristensen","year":"2000","journal-title":"BMJ"},{"issue":"10","key":"zoi230439r13","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/tmi.2005.10.issue-10","article-title":"Non-specific effects of vaccination on child survival? a prospective study in Senegal.","volume":"10","author":"Elguero","year":"2005","journal-title":"Trop Med Int Health"},{"issue":"4","key":"zoi230439r14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.187.4.561","article-title":"Infection of mice with Mycobacterium bovis-bacillus Calmette-Gu\u00e9rin (BCG) suppresses allergen-induced airway eosinophilia.","volume":"187","author":"Erb","year":"1998","journal-title":"J Exp Med"},{"issue":"8","key":"zoi230439r15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/all.2004.59.issue-8","article-title":"Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG.","volume":"59","author":"da Cunha","year":"2004","journal-title":"Allergy"},{"issue":"5296","key":"zoi230439r16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.275.5296.77","article-title":"The inverse association between tuberculin responses and atopic disorder.","volume":"275","author":"Shirakawa","year":"1997","journal-title":"Science"},{"issue":"1","key":"zoi230439r17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41541-018-0062-8","article-title":"Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations.","volume":"3","author":"K\u00fchtreiber","year":"2018","journal-title":"NPJ Vaccines"},{"issue":"10","key":"zoi230439r18","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2337\/diacare.22.10.1703","article-title":"Effect of bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes: a randomized clinical study.","volume":"22","author":"Allen","year":"1999","journal-title":"Diabetes Care"},{"issue":"8899","key":"zoi230439r19","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0140-6736(94)91583-0","article-title":"Effect of adjuvant therapy on development of diabetes in mouse and man.","volume":"343","author":"Shehadeh","year":"1994","journal-title":"Lancet"},{"issue":"7","key":"zoi230439r20","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1212\/WNL.53.7.1588","article-title":"Use of bacille Calmette-Gu\u00e8rin (BCG) in multiple sclerosis.","volume":"53","author":"Ristori","year":"1999","journal-title":"Neurology"},{"issue":"9","key":"zoi230439r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100728","article-title":"Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes.","volume":"3","author":"Faustman","year":"2022","journal-title":"Cell Rep Med"},{"issue":"4","key":"zoi230439r22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00000658-197410000-00029","article-title":"BCG immunotherapy of malignant melanoma: summary of a seven-year experience.","volume":"180","author":"Morton","year":"1974","journal-title":"Ann Surg"},{"issue":"1","key":"zoi230439r23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.juro.2007.08.122","article-title":"History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.","volume":"179","author":"Herr","year":"2008","journal-title":"J Urol"},{"issue":"9165","key":"zoi230439r24","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20 years on.","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"issue":"11","key":"zoi230439r25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224433","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) therapy lowers the incidence of Alzheimer\u2019s disease in bladder cancer patients.","volume":"14","author":"Gofrit","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"zoi230439r26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines9050491","article-title":"Bladder cancer immunotherapy by BCG is associated with a significantly reduced risk of Alzheimer\u2019s disease and Parkinson\u2019s disease.","volume":"9","author":"Klinger","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"zoi230439r27","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.1016\/j.clgc.2021.05.001","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin treatment is inversely associated with the risk of developing Alzheimer disease or other dementia among patients with non\u2013muscle-invasive bladder cancer.","volume":"19","author":"Kim","year":"2021","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"zoi230439r28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/alz.v18.3","article-title":"The epidemiology is promising, but the trial evidence is weak: why pharmacological dementia risk reduction trials haven\u2019t lived up to expectations, and where do we go from here?","volume":"18","author":"Peters","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"4","key":"zoi230439r29","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non\u2013muscle invasive bladder cancer: AUA\/SUO guideline.","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"issue":"1","key":"zoi230439r31","doi-asserted-by":"publisher","first-page":"7652","DOI":"10.1038\/s41467-022-35157-w","article-title":"Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia.","volume":"13","author":"Charpignon","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"zoi230439r32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"23","key":"zoi230439r33","doi-asserted-by":"publisher","first-page":"648","DOI":"10.21105\/joss","article-title":"Comorbidity: an R package for computing comorbidity scores.","volume":"3","author":"Gasparini","year":"2018","journal-title":"J Open Source Softw"},{"issue":"11","key":"zoi230439r34","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"3","key":"zoi230439r35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: possibilities and pitfalls.","volume":"41","author":"Andersen","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"4","key":"zoi230439r37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the e-value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"5","key":"zoi230439r38","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Web site and R package for computing e-values.","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"issue":"1","key":"zoi230439r39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity.","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"43","key":"zoi230439r40","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes.","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"zoi230439r41","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","article-title":"BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment.","volume":"28","author":"Cirovic","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"6284","key":"zoi230439r42","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease.","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"issue":"2","key":"zoi230439r43","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00415-003-0967-6","article-title":"The effect of bacille Calmette-Gu\u00e9rin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS.","volume":"250","author":"Paolillo","year":"2003","journal-title":"J Neurol"},{"issue":"1","key":"zoi230439r44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/01.wnl.0000438216.93319.ab","article-title":"Effects of bacille Calmette-Guerin after the first demyelinating event in the CNS.","volume":"82","author":"Ristori","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"zoi230439r45","doi-asserted-by":"publisher","first-page":"14933","DOI":"10.1038\/s41598-021-94529-2","article-title":"BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation.","volume":"11","author":"Keefe","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"zoi230439r46","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer.","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"4","key":"zoi230439r47","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.juro.2008.11.124","article-title":"Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus Calmette-Guerin therapy in patients with superficial bladder cancer.","volume":"181","author":"Bisiaux","year":"2009","journal-title":"J Urol"},{"issue":"7701","key":"zoi230439r48","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","article-title":"Innate immune memory in the brain shapes neurological disease hallmarks.","volume":"556","author":"Wendeln","year":"2018","journal-title":"Nature"},{"key":"zoi230439r49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.nbd.2017.02.001","article-title":"Immunization with bacillus Calmette-Gu\u00e9rin (BCG) alleviates neuroinflammation and cognitive deficits in APP\/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain.","volume":"101","author":"Zuo","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"6","key":"zoi230439r50","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2121568","article-title":"Changes in dendritic complexity and spine morphology following BCG immunization in APP\/PS1 mice.","volume":"18","author":"Li","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"zoi230439r51","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jalz.2017.06.2270","article-title":"Dementia prevalence and incidence in a federation of European electronic health record databases: the European Medical Informatics Framework resource.","volume":"14","author":"Perera","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"3","key":"zoi230439r52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1212\/WNL.0b013e318225c6bc","article-title":"Nontraditional risk factors combine to predict Alzheimer disease and dementia.","volume":"77","author":"Song","year":"2011","journal-title":"Neurology"},{"key":"zoi230439r9","unstructured":"Centers for Disease Control and Prevention. Vaccines and immunizations. February 16, 2021. Accessed January 6, 2023. https:\/\/www.cdc.gov\/vaccines\/index.html"},{"key":"zoi230439r10","unstructured":"Locht? C. The history of BCG. Nor NM, Acosta A, Sarmiento ME, eds. The Art & Science of Tuberculosis Vaccine Development. 2nd ed. Oxford University Press; 2010. Accessed April 10, 2023. http:\/\/tbvaccines.usm.my\/finlay\/sites\/default\/files\/Chapter%205.01.pdf"},{"key":"zoi230439r30","unstructured":"Mostofi? FK, Sobin? LH, Torloni? H. Histological typing of urinary bladder tumours. World Health Organization. 1973. Accessed April 10, 2023. https:\/\/apps.who.int\/iris\/handle\/10665\/41533"},{"key":"zoi230439r36","doi-asserted-by":"crossref","unstructured":"Vakulenko-Lagun? B, Charpignon? ML, Zheng? B, Albers? M, Das? S. causalCmprsk: nonparametric and Cox-based estimation of average treatment effects in competing risks. 2023. Accessed April 10, 2023. https:\/\/CRAN.R-project.org\/package=causalCmprsk","DOI":"10.1016\/j.cmpb.2023.107819"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2805030\/weinberg_2023_oi_230439_1683733585.48551.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T12:15:20Z","timestamp":1702469720000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2805030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.14336","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}